DEC 01, 2016 8:00 AM PST

In Vivo Imaging Toolkit: Advancing Preclinical and Translational Science in Molecular and Orthopedic Research at UCLA

Speakers
  • Chief, Division of Musculoskeletal Oncology Director, UCLA Global Orthopaedic Initiative, Department of Orthopaedic Surgery, David Geffen School of Medicine at UCLA
    Biography
      Dr. Bernthal is an orthopaedic oncologist who has been on the UCLA faculty since 2013. He graduated magna cum laude and phi beta kappa from Princeton University and received alpha omega alpha honors from Cornell University Medical School. He did his residency at UCLA in orthopaedic surgery and did fellowships in orthopaedic research and musculoskeletal oncology at UCLA and the Huntsman Cancer Institute, respectively. His clinical interests are bone and soft tissue tumors and his laboratory is pioneering new implant coatings to prevent surgical infections.
    • Director, Preclinical Imaging Technology Center, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology (DMMP), David Geffen School of Medicine at UCLA
      Biography
        Dr. Lee received his Ph.D. in DMMP under Dr. Caius Radu and his postdoctoral training in molecular imaging at Memorial Sloan Kettering Cancer Center under Dr. Vladimir Ponomarev. His work focuses on the development and integration of in vivo imaging assays to quantitatively assess the functional dynamics of health and disease, and to study associated therapeutic interventions in preclinical models.

      Abstract
      DATE: December 1, 2016
      TIME:  8:00 AM PT, 11:00 AM ET


      Preclinical imaging enables the measurement and assessment of biological processes in vivo utilizing technologies such as bioluminescence, fluorescence and positron emission tomography (PET) platforms to assay cells, tissues, and living organisms. PerkinElmer’s suite of optical and PET scanners set the industry standard for sensitivity, quantitative accuracy, and data reproducibility. This enables premier research institutions like UCLA the opportunity to advance preclinical and translational science while fostering collaboration among imaging laboratories both internally and externally. In this institutional highlight webinar series, we are excited to share insight on how a successful imaging program at UCLA has been instrumental in generating novel models of disease and conducting cutting edge research.
       
      You will hear from Dr. Jason Lee, Director of the Preclinical Imaging Technology Center, Crump Institute for Molecular Imaging, who will highlight imaging technologies available for preclinical research and their applications in biomedical and translational studies at the Crump Institute and at UCLA. He will be followed by Dr. Nick Bernthal, Chief, Division of Musculoskeletal Oncology and Director, UCLA Global Orthopaedic Initiative, who will present collaborative work between groups at UCLA, Johns Hopkins, and USC who developed and examined a preclinical model of posterior-approach spinal surgery. Employing several imaging modalities, these studies demonstrate a successful model for noninvasive, in vivo examination of spine implant infection where both bacterial burden and host inflammation can be monitored longitudinally in real-time without requiring animal sacrifice.
       
      Join us to learn how successful research institutions are using in vivo imaging to aid their ongoing preclinical and translational research programs.  Doctors Lee and Bernthal will be happy to answer your questions following the presentation.
       

      Show Resources
      You May Also Like
      NOV 18, 2020 8:00 AM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      NOV 18, 2020 8:00 AM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
      OCT 08, 2020 7:00 AM PDT
      C.E. CREDITS
      OCT 08, 2020 7:00 AM PDT
      DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
      OCT 29, 2020 6:00 AM PDT
      C.E. CREDITS
      OCT 29, 2020 6:00 AM PDT
      Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
      NOV 16, 2020 8:00 AM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      NOV 16, 2020 8:00 AM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
      JUN 23, 2020 10:00 AM PDT
      C.E. CREDITS
      JUN 23, 2020 10:00 AM PDT
      DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
      SEP 10, 2020 9:00 AM PDT
      C.E. CREDITS
      SEP 10, 2020 9:00 AM PDT
      Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
      Loading Comments...
      Show Resources